Soleno Therapeutics, Inc.

Direct answer

Soleno Therapeutics, Inc. is publicly traded on NASDAQ under the ticker SLNO.

Soleno Therapeutics, Inc. (SLNO) operates as a clinical-stage biopharmaceutical company, specializing in the creation and market introduction of groundbreaking treatments for uncommon illnesses. The cornerstone of its therapeutic pipeline is Diazoxide Choline Controlled-Release, a once-daily oral tablet aimed at addressing Prader-Willi Syndrome, currently progressing through an active Phase III clinical evaluation....

Can you invest in Soleno Therapeutics, Inc.?

Yes. Soleno Therapeutics, Inc. is publicly traded on NASDAQ under the ticker SLNO.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Soleno Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.